← Ishga qaytish
Ushbu ish iqtibos qilgan ishlar
57 ta ish
Ish: Next-Generation Chimeric Antigen Receptor Platforms for Skin Cancer Immunotherapy: Biological Rationale, Therapeutic Opportunities, and Precision Selection Strategies
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi, Steven O’Day, David F. McDermott +26
MaqolaOchiq kirish201010 iqtibosABIIdecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma
Nikhil C. Munshi, Larry D. Anderson, Nina Shah +25
Maqola20217 iqtibosABIUse of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors
Enli Liu, David Marín, Pinaki P. Banerjee +24
Maqola20207 iqtibosABIUnderstanding the tumor immune microenvironment (TIME) for effective therapy
Mikhail Binnewies, Edward W. Roberts, Kelly Kersten +15
Sharh maqolaOchiq kirish20186 iqtibosABITargeting macrophages: therapeutic approaches in cancer
Luca Cassetta, Jeffrey W. Pollard
Sharh maqolaOchiq kirish20185 iqtibosABIPrimary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Padmanee Sharma, Siwen Hu‐Lieskovan, Jennifer A. Wargo +1
Sharh maqola20174 iqtibosABIMacrophage Diversity Enhances Tumor Progression and Metastasis
Bin‐Zhi Qian, Jeffrey W. Pollard
Sharh maqolaOchiq kirish20103 iqtibosABICombined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
James Larkin, Vanna Chiarion‐Sileni, René González +28
MaqolaOchiq kirish20153 iqtibosABI